We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUDG.L Regulatory News (UDG)

  • There is currently no data for UDG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme Effective and Completion of the Acquisition

16 Aug 2021 11:45

RNS Number : 7722I
UDG Healthcare Public Limited Co.
16 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

16 August 2021 

Increased and Final Recommended Cash Offer for

UDG Healthcare plc

by

Nenelite Limited

 (a newly incorporated company and Affiliate of Clayton, Dubilier & Rice, LLC as manager of CD&R Funds X and XI)

to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014

 

scheme effective and completion of the acquisition

The boards of Nenelite Limited ("Bidco") and UDG Healthcare plc ("UDG") are pleased to announce that the scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 (the "Scheme") in connection with the increased and final recommended cash offer by Bidco, an Affiliate of Clayton, Dubilier & Rice, LLC ("CD&R"), for the entire issued and to be issued share capital of UDG (the "Acquisition"), became effective today, 16 August 2021.

Despatch of cheques and electronic transfers to Euroclear Bank for the cash consideration payable by Bidco to Scheme Shareholders under the terms of the Scheme will be effected by no later than 30 August 2021.

The cancellation of listing of UDG Shares on the Official List of the FCA and of trading in UDG Shares on the Main Market of the London Stock Exchange is expected to occur by 8.00 a.m. (Dublin time) on 17 August 2021.

Capitalised terms used, but not defined, in this announcement have the same meaning as in the Revised Scheme Document dated 7 July 2021.

Enquiries:

UDG

Tel: + 353 (0) 1 468 9000

Brendan McAtamney / Nigel Clerkin / Damien Moynagh / Keith Byrne

 

Goldman Sachs International (financial adviser to UDG)

Tel: +44 (0) 20 7774 1000

Ben Thorpe / Chris Emmerson / Skylar Dabbar

 

 

 

Rothschild & Co (financial adviser to UDG)

Tel: +44 (0) 20 7280 5000

Hedley Goldberg / Julian Hudson / Ashley Southcott

 

 

 

Davy (corporate broker and corporate finance adviser to UDG)

Tel: +353 (0) 1 679 7788

Ronan Veale / Brian Garrahy

 

 

 

Liberum (corporate broker to UDG)

Tel: +44 (0) 20 3100 2000

John Fishley

 

 

 

Peel Hunt (corporate broker to UDG)

Tel: +44 (0) 20 7418 8900

James Steel

 

 

 

Powerscourt (PR adviser to UDG)

Tel: +44 (0) 20 7250 1446

Lisa Kavanagh / Eavan Gannon / Jack Hickey

 

 

Statements Required by the Takeover Rules

The UDG Directors accept responsibility for the information contained in this announcement relating to UDG, the UDG Group and the UDG Directors and members of their immediate families, related trusts and persons connected with them. To the best of the knowledge and belief of the UDG Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

Goldman Sachs International, which is authorised by the PRA and regulated by the PRA and the FCA in the United Kingdom, is acting as financial adviser to UDG and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Goldman Sachs International nor for providing advice in connection with any matter referred to herein. Goldman Sachs International has given, and not withdrawn, its consent to the inclusion of its advice in this announcement in the form and context in which it is included.

N.M. Rothschild and Sons Limited ("Rothschild & Co"), which is authorised and regulated by the FCA in the United Kingdom, is acting as financial adviser to UDG, including providing independent financial advice to the UDG Directors for the purposes of Rule 3 of the Takeover Rules, and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Rothschild & Co nor for providing advice in connection with any matter referred to herein. Neither Rothschild & Co nor any of its affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild & Co in connection with this announcement, any statement contained herein, the Acquisition or otherwise. Rothschild & Co has given, and not withdrawn, its consent to the inclusion of its advice in this announcement in the form and context in which it is included.

J&E Davy ("Davy"), which is authorised and regulated in Ireland by the Central Bank of Ireland, is acting as corporate broker and corporate finance adviser to UDG and no one else in connection with the matters described in this announcement and will not be responsible to any person for providing the protections afforded to customers of Davy or for advising any other person in connection with any matter referred to herein.

Liberum Capital Limited, which is authorised and regulated by the FCA, is acting as corporate broker to UDG and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Liberum Capital Limited nor for providing advice in connection with any matter referred to herein.

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the FCA, is acting as corporate broker for UDG and for no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than UDG for providing the protections afforded to clients of Peel Hunt or for providing advice in connection with any matter referred to herein.

General

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. The Acquisition will be made solely through the Scheme Document and the Revised Scheme Document (or, if the Acquisition is implemented by way of a Takeover Offer, the offer document), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any acceptance or other response to the Acquisition should be made only on the basis of the information in the Scheme Document and the Revised Scheme Document (or, if the Acquisition is implemented by way of a Takeover Offer, the offer document).

Overseas Shareholders

The availability of the Acquisition to UDG Shareholders who are not resident in and citizens of Ireland or the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Persons who are not resident in Ireland or the United Kingdom should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. In particular, the ability of persons who are not resident in Ireland or the United Kingdom to vote their UDG Shares with respect to the Scheme at the Adjourned Scheme Meeting, or to appoint another person as proxy to vote at the Adjourned Scheme Meeting on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. Further details in relation to Overseas Shareholders will be contained in the Revised Scheme Document.

Unless otherwise determined by Bidco or required by the Takeover Rules, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Scheme by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), the Takeover Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Takeover Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUPCRUPGGUQ
Date   Source Headline
16th Aug 20213:40 pmBUSForm 8.3 - UDG HEALTHCARE PLC - Amendment
16th Aug 20213:30 pmGNWForm 8.3 - UDG Healthcare plc
16th Aug 20213:30 pmBUSForm 8.3 - UDG Healthcare plc
16th Aug 202112:14 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - UDG Healthcare plc - Ordinary shares
16th Aug 202112:00 pmRNSForm 38.5 (a) UDG Healthcare Group Plc
16th Aug 202111:45 amRNSScheme Effective and Completion of the Acquisition
16th Aug 202111:41 amBUSFORM 8.3 - UDG HEALTHCARE PLC
16th Aug 202111:12 amRNSUDG Healthcare Plc 38.5a
16th Aug 202110:48 amRNSForm 38.5b - UDG Healthcare plc
16th Aug 202110:46 amRNSForm 38.5b - UDG Healthcare plc
16th Aug 202110:44 amRNSForm 38.5a - UDG Healthcare plc
16th Aug 20219:57 amRNSForm 38.5(a) (EPT/RI)
16th Aug 20217:19 amRNSForm 8.3 - UDG Healthcare plc
16th Aug 20217:00 amRNSForm 38.5a - UDG Healthcare plc - Amendment
13th Aug 20215:24 pmRNSHolding(s) in Company
13th Aug 20213:20 pmGNWForm 8.3 - UDG Healthcare plc
13th Aug 20213:15 pmBUSForm 8.3 - UDG Healthcare plc
13th Aug 202112:26 pmRNSForm 38.5(a) - Replacement UDG Healthcare Group
13th Aug 202112:16 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - UDG Healthcare plc - Ordinary shares
13th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - UDG Healthcare Plc
13th Aug 202111:36 amRNSUDG Healthcare Plc 38.5a
13th Aug 202111:13 amBUSForm 8.3 - UDG HEALTHCARE PLC
13th Aug 202110:38 amRNSForm 38.5b - UDG Healthcare plc
13th Aug 202110:37 amRNSForm 38.5b - UDG Healthcare plc
13th Aug 202110:35 amRNSForm 38.5a - UDG Healthcare plc
13th Aug 20219:45 amRNSForm 38.5 (a) (EPT/RI)
13th Aug 20217:00 amRNSForm 38.5a - UDG Healthcare plc - Amendment
13th Aug 20217:00 amRNSForm 38.5a - UDG Healthcare plc - Amendment
12th Aug 20214:45 pmRNSUpdate on Scheme Timetable to Completion
12th Aug 20214:32 pmRNSUDG Healthcare Plc Amnd 38.5a
12th Aug 20214:30 pmRNSUDG Healthcare Plc Amnd 38.5a
12th Aug 20214:30 pmRNSHolding(s) in Company
12th Aug 20214:30 pmRNSHolding(s) in Company
12th Aug 20213:30 pmRNSForm 8.3 - UDG LN
12th Aug 20213:15 pmBUSForm 8.3 - UDG Healthcare plc
12th Aug 202112:00 pmRNSForm 8.5 (EPT/RI) - UDG Healthcare Plc
12th Aug 202111:36 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - UDG Healthcare plc - Ordinary shares
12th Aug 202111:27 amRNSUDG Healthcare Plc 38.5a
12th Aug 202111:11 amRNSForm 38.5b - UDG Healthcare plc
12th Aug 202111:08 amRNSForm 38.5a (EPT/RI) - UDG Healthcare plc
12th Aug 202111:01 amRNSForm 38.5b - UDG Healthcare plc
12th Aug 202111:00 amRNSForm 38.5a - UDG Healthcare plc
12th Aug 202110:54 amBUSForm 8.3 - UDG Healthcare plc
12th Aug 20219:46 amRNSForm 8.3 - UDG Healthcare Plc
11th Aug 20214:30 pmRNSHolding(s) in Company
11th Aug 20213:30 pmRNSForm 8.3 - UDG LN
11th Aug 20213:30 pmGNWForm 8.3 - UDG Healthcare plc
11th Aug 20213:15 pmBUSForm 8.3 - UDG Healthcare plc
11th Aug 202112:13 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - UDG Healthcare plc - Ordinary shares
11th Aug 202111:35 amRNSUDG Healthcare Plc 38.5a

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.